AKT1 and cancer: Studies have demonstrated that aberrant activation of the PI3K/AKT pathway in tumors promotes cancer progression through direct modulation of nutrient transporters and metabolic enzymes, as well as regulation of transcription factors governing the expression of key metabolic components and downstream metabolic cascades (Hoxhaj and Manning, 2020).